MIV Therapeutics Inc.
MIV THERAPEUTICS INC WELCOMES ITS NEW LEADER
MIV Therapeutics Inc. / Key word(s): Change of Personnel MIV THERAPEUTICS INC WELCOMES ITS NEW LEADER May 18th, 2013 MIV Therapeutics, Inc. (the ‘Company’ or ‘MIV’) announced today that MIV accept the resignation of Mr. Chris Chen as director and officer while welcome its new leader, Chairman & CEO Mr. XIAO. Mr. XIAO says, ‘ Even though the company has experience lots of turmoil for the last few years but I do have the confidence to move it forward. We are currently working with a medical fund to be our strategic partner so as to initiate the CE Marking application. It’s time now to reveal the real value of the technologies and bring back our shareholders investment returns. Nevertheless, the company has been bothering by its former US based patent lawyer Mr. John Rissman along with his collection agent Mr. Alan Cohen, those who might possibly in the future proved to be wrongly using unnecessary and inappropriate means including using fraudulent and illegally obtained documents to treat their opponents, as their way of business doing. Whether or not this is true, we will definitely find out. I believe my special expertise would help me better deal with the enemies in the market place who have been bringing turmoil to the company and smooth whatever possible transaction. It’s time for the company to prevail. I will launch a full investigation to conduct a legitimate searching while taking the company to positive cash flow era. With the sufficient clinical data, we are in the position of a great advantage and huge potential markets in Asia, Europe as well as South America.’ About MIV Therapeutics, Inc. MIV Therapeutics, Inc. is a development stage company in the business of developing next-generation coatings and drug-delivery systems for cardiovascular stents and other implantable medical devices. Safe Harbour Statements Except for the statements of historical fact contained herein, the information presented in this news release constitutes ‘forward-looking statements’ as such term is used in applicable United States and Canadian laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as ‘expects’ or ‘does not expect’, ‘is expected’, ‘anticipates’ or ‘does not anticipate’, ‘plans, ‘estimates’ or ‘intends’, or stating that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘might’ or ‘will’ be taken, occur or be achieved) are not statements of historical fact and should be viewed as ‘forward-looking statements’. Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law. Although the Company believes that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance those beliefs, plans, expectations or intentions will prove to be accurate. Such forward-looking statements reflect our current views with respect to future events and are subject to certain risks, uncertainties and assumptions, including, the risks and uncertainties outlined in our most recent financial statements and reports filed with the United States Securities and Exchange Commission (the ‘SEC’) (available at www.sec.gov) and with Canadian securities administrators (available at www.sedar.com). Investors should consider all of the information set forth herein and should also refer to the risk factors disclosed in the Company’s periodic reports filed from time-to-time with the SEC. The Company again cautions investors that the Company is not up-to-date in its SEC or SEDAR filings. Pink OTC Markets has discontinued the display of quotes on otcmarkets.com for the Company’s securities because the Company’s securities have been labeled Caveat Emptor (Buyer Beware) and because adequate current information has not been made available by the Company. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities of the Company nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. End of Corporate News 05.06.2013 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
215046 05.06.2013 |